Evaluation of the effect of Eplerenone in Central serous chorioretinopathy )CSCR

Phase 1

Recruiting

• Conditions: Chronic central serous chorioretinopathy.; Central serous chorioretinopathy; H35.71

• Registration Number: IRCT20220122053792N1
• Lead Sponsor: Oroumia University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 8 March 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 34

Inclusion Criteria

Patients with chronic central serous chorioretinopathy

Exclusion Criteria

Elevated potassium levels in preoperative blood testsor
contraindications in comprehensive medical examination
renal impairment
severe hepatic impairment
known allergies to any of the components of the drug

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The patient's best corrected vision. Timepoint: Before and one month after the start of the intervention. Method of measurement: snellen chart.